Catalyst4, Inc.
Catalyst4, Inc., 10%, reported an open-market or private purchase at MapLight Therapeutics, Inc. involving 4400000.000000 shares for an estimated $50072000.00. Reported holdings after the transaction were 25306689.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 14, 2026
- Filing date
- Aug 18, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 20,906,689 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
MLPT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001900201-26-000005 Voting Common Stock
- Transaction date
- Aug 14, 2026 Filed Aug 18, 2026, 10:55 PM · 4d delay
- Shares
- 4,400,000 sh $11.38 per share
- Estimated value
- $50.0M Computed from shares × price
- Holdings after
- 25,306,689 sh Indirect · See footnote
Filing signal explanations
Badges describe filing facts only — not predictions.
+26 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - ten_percent_owner_buy+4 points
is_ten_percent_owner = true
10% beneficial owner open-market purchase. - large_buy_absolute+10 points
large-buy signal with absolute_triggered = true
Open-market purchase exceeds the configured absolute threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The shares are held of record by Catalyst4, Inc. ("Catalyst4"). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power w…
- F2
The warrant is immediately exercisable, however, the warrant may not be exercised if the aggregate number of shares of voting common stock beneficially owned by the reporting person immediately follow…
- F3
The warrants will not expire until exercised in full.
0 other transactions
0 recent txs